The Validation of a New Visual Anaemia Evaluation Tool HemoHue HH1 in Patients with End-Stage Renal Disease
In chronic haemodialysis patients, anaemia is a frequent finding associated with high therapeutic costs and further expenses resulting from serial laboratory measurements. HemoHue HH1, HemoHue Ltd, is a novel tool consisting of a visual scale for the noninvasive assessment of anaemia by matching the...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Anemia |
| Online Access: | http://dx.doi.org/10.1155/2013/424076 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850223646481580032 |
|---|---|
| author | Robert M. Kalicki Stefan Farese Dominik E. Uehlinger |
| author_facet | Robert M. Kalicki Stefan Farese Dominik E. Uehlinger |
| author_sort | Robert M. Kalicki |
| collection | DOAJ |
| description | In chronic haemodialysis patients, anaemia is a frequent finding associated with high therapeutic costs and further expenses resulting from serial laboratory measurements. HemoHue HH1, HemoHue Ltd, is a novel tool consisting of a visual scale for the noninvasive assessment of anaemia by matching the coloration of the conjunctiva with a calibrated hue scale. The aim of the study was to investigate the usefulness of HemoHue in estimating individual haemoglobin concentrations and binary treatment outcomes in haemodialysis patients. A prospective blinded study with 80 hemodialysis patients comparing the visual haemoglobin assessment with the standard laboratory measurement was performed. Each patient’s haemoglobin concentration was estimated by seven different medical and nonmedical observers with variable degrees of clinical experience on two different occasions. The estimated population mean was close to the measured one (11.06 ± 1.67 versus 11.32 ± 1.23 g/dL, ). A learning effect could be detected. Relative errors in individual estimates reached, however, up to 50%. Insufficient performance in predicting binary outcomes (ROC AUC: 0.72 to 0.78) and poor interrater reliability (Kappa < 0.6) further characterised this method. |
| format | Article |
| id | doaj-art-43e44170f2ac4c4390094c26b69f2ee2 |
| institution | OA Journals |
| issn | 2090-1267 2090-1275 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Anemia |
| spelling | doaj-art-43e44170f2ac4c4390094c26b69f2ee22025-08-20T02:05:52ZengWileyAnemia2090-12672090-12752013-01-01201310.1155/2013/424076424076The Validation of a New Visual Anaemia Evaluation Tool HemoHue HH1 in Patients with End-Stage Renal DiseaseRobert M. Kalicki0Stefan Farese1Dominik E. Uehlinger2Department of Nephrology, Hypertension and Clinical Pharmacology, Inselspital Bern, University Hospital and University of Bern, Freiburgstrasse 15, 3010 Bern, SwitzerlandDepartment of Nephrology, Hypertension and Clinical Pharmacology, Inselspital Bern, University Hospital and University of Bern, Freiburgstrasse 15, 3010 Bern, SwitzerlandDepartment of Nephrology, Hypertension and Clinical Pharmacology, Inselspital Bern, University Hospital and University of Bern, Freiburgstrasse 15, 3010 Bern, SwitzerlandIn chronic haemodialysis patients, anaemia is a frequent finding associated with high therapeutic costs and further expenses resulting from serial laboratory measurements. HemoHue HH1, HemoHue Ltd, is a novel tool consisting of a visual scale for the noninvasive assessment of anaemia by matching the coloration of the conjunctiva with a calibrated hue scale. The aim of the study was to investigate the usefulness of HemoHue in estimating individual haemoglobin concentrations and binary treatment outcomes in haemodialysis patients. A prospective blinded study with 80 hemodialysis patients comparing the visual haemoglobin assessment with the standard laboratory measurement was performed. Each patient’s haemoglobin concentration was estimated by seven different medical and nonmedical observers with variable degrees of clinical experience on two different occasions. The estimated population mean was close to the measured one (11.06 ± 1.67 versus 11.32 ± 1.23 g/dL, ). A learning effect could be detected. Relative errors in individual estimates reached, however, up to 50%. Insufficient performance in predicting binary outcomes (ROC AUC: 0.72 to 0.78) and poor interrater reliability (Kappa < 0.6) further characterised this method.http://dx.doi.org/10.1155/2013/424076 |
| spellingShingle | Robert M. Kalicki Stefan Farese Dominik E. Uehlinger The Validation of a New Visual Anaemia Evaluation Tool HemoHue HH1 in Patients with End-Stage Renal Disease Anemia |
| title | The Validation of a New Visual Anaemia Evaluation Tool HemoHue HH1 in Patients with End-Stage Renal Disease |
| title_full | The Validation of a New Visual Anaemia Evaluation Tool HemoHue HH1 in Patients with End-Stage Renal Disease |
| title_fullStr | The Validation of a New Visual Anaemia Evaluation Tool HemoHue HH1 in Patients with End-Stage Renal Disease |
| title_full_unstemmed | The Validation of a New Visual Anaemia Evaluation Tool HemoHue HH1 in Patients with End-Stage Renal Disease |
| title_short | The Validation of a New Visual Anaemia Evaluation Tool HemoHue HH1 in Patients with End-Stage Renal Disease |
| title_sort | validation of a new visual anaemia evaluation tool hemohue hh1 in patients with end stage renal disease |
| url | http://dx.doi.org/10.1155/2013/424076 |
| work_keys_str_mv | AT robertmkalicki thevalidationofanewvisualanaemiaevaluationtoolhemohuehh1inpatientswithendstagerenaldisease AT stefanfarese thevalidationofanewvisualanaemiaevaluationtoolhemohuehh1inpatientswithendstagerenaldisease AT dominikeuehlinger thevalidationofanewvisualanaemiaevaluationtoolhemohuehh1inpatientswithendstagerenaldisease AT robertmkalicki validationofanewvisualanaemiaevaluationtoolhemohuehh1inpatientswithendstagerenaldisease AT stefanfarese validationofanewvisualanaemiaevaluationtoolhemohuehh1inpatientswithendstagerenaldisease AT dominikeuehlinger validationofanewvisualanaemiaevaluationtoolhemohuehh1inpatientswithendstagerenaldisease |